Position in MRNA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$8,301,837
+$4,369,995 QoQ
Shares Held
163,422
+22.6% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Derivatives in MRNA
reported options exposure · as of Dec 31, 2025CallValue
$44,235
CallShares
1,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Vontobel Holding Ltd. holds $92,341,956 across 47 Biotechnology names. MRNA ranks #3 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
83,380 | $37,232,503 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
28,794 | $22,247,395 | |
| 3 | MRNA |
Moderna, Inc.
This page
|
163,422 | $8,301,837 | |
| 4 | BNTX |
BioNTech SE
|
93,107 | $8,275,350 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,476 | $1,811,842 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
17,872 | $1,327,174 | |
| 7 | MCRB |
Seres Therapeutics, Inc.
|
138,468 | $1,228,211 | |
| 8 | OCUL |
Ocular Therapeutix, Inc
|
135,605 | $1,148,574 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,301,837 | 163,422 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $44,235 | 1,500 | Call | Defined | 2026-02-13 | |
| 2025-12-31 | $3,931,842 | 133,328 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $5,729,197 | 221,804 | Shares | Defined | 2025-10-15 | |
| 2025-09-30 | $38,745 | 1,500 | Call | Defined | 2025-10-15 | |
| 2025-06-30 | $33,108 | 1,200 | Call | Defined | 2025-07-23 | |
| 2025-06-30 | $8,997,925 | 326,130 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $7,419,364 | 261,706 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $10,742,939 | 258,368 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $7,758,160 | 116,088 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $5,554,530 | 46,775 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,289,825 | 30,873 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $5,073,938 | 51,020 | Shares | Defined | 2024-06-04 | |
| 2023-09-30 | $4,866,610 | 47,116 | Shares | Defined | 2024-06-04 | |
| 2023-06-30 | $9,011,897 | 74,172 | Shares | Defined | 2024-06-04 | |
| 2023-03-31 | $8,821,173 | 57,437 | Shares | Defined | 2024-06-04 | |
| 2022-12-31 | $7,360,826 | 40,980 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $17,916,765 | 151,516 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $31,834,407 | 222,852 | Shares | Defined | 2022-07-27 | |
| 2022-03-31 | $19,531,699 | 113,385 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $28,201,429 | 111,038 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $48,859,130 | 126,953 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $30,193,049 | 128,492 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $7,692,132 | 58,741 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $8,500,095 | 81,364 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||